COVID-19 randomised trial protocols: Rapid publication without barriers

Shaun Treweek; Peter Jüni; Tianjing Li; Jonathan Collin; Matthias Briel; An Wen Chan; Karla Hemming; William J. Meurer; Matthew R. Sydes; Jeremy M. Grimshaw

doi:10.1186/s13063-020-04304-3

COVID-19 randomised trial protocols: Rapid publication without barriers

Shaun Treweek^*
, Peter Jüni
, Tianjing Li
, Jonathan Collin
, Matthias Briel
, An Wen Chan
, Karla Hemming
, William J. Meurer
, Matthew R. Sydes
, Jeremy M. Grimshaw

^*Corresponding author for this work

University of Toronto
University of Colorado Denver
Bmc
University of Basel
University of Birmingham
University of Michigan, Ann Arbor
University College London
Ottawa Hospital Research Institute

Research output: Contribution to journal › Editorial › peer-review

4 Citations (Scopus)

8 Downloads (Pure)

Abstract

We are living in extraordinary times. COVID-19 is having a profound effect on every aspect of our lives. Most who read this will do so from their own homes. It will have been weeks since many of us were at our normal place of work, and it is likely to be many weeks, probably months, before we are back there. Videoconferencing is becoming second nature for us all.

Original language	English
Article number	327
Number of pages	2
Journal	Trials
Volume	21
Issue number	1
Early online date	15 Apr 2020
DOIs	https://doi.org/10.1186/s13063-020-04304-3
Publication status	Published - 15 Apr 2020

Keywords

COVID-19

Access to Document

10.1186/s13063-020-04304-3Licence: CC BY

Treweek_etal_T_Covid-19_Randomised_Trial_VoR
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/
Final published version, 424 KBLicence: CC BY

Cite this

@article{36909265a2494064a97bbd13231662eb,

title = "COVID-19 randomised trial protocols: Rapid publication without barriers",

abstract = "We are living in extraordinary times. COVID-19 is having a profound effect on every aspect of our lives. Most who read this will do so from their own homes. It will have been weeks since many of us were at our normal place of work, and it is likely to be many weeks, probably months, before we are back there. Videoconferencing is becoming second nature for us all.",

keywords = "COVID-19",

author = "Shaun Treweek and Peter J{\"u}ni and Tianjing Li and Jonathan Collin and Matthias Briel and Chan, \{An Wen\} and Karla Hemming and Meurer, \{William J.\} and Sydes, \{Matthew R.\} and Grimshaw, \{Jeremy M.\}",

year = "2020",

month = apr,

day = "15",

doi = "10.1186/s13063-020-04304-3",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - COVID-19 randomised trial protocols

T2 - Rapid publication without barriers

AU - Treweek, Shaun

AU - Jüni, Peter

AU - Li, Tianjing

AU - Collin, Jonathan

AU - Briel, Matthias

AU - Chan, An Wen

AU - Hemming, Karla

AU - Meurer, William J.

AU - Sydes, Matthew R.

AU - Grimshaw, Jeremy M.

PY - 2020/4/15

Y1 - 2020/4/15

N2 - We are living in extraordinary times. COVID-19 is having a profound effect on every aspect of our lives. Most who read this will do so from their own homes. It will have been weeks since many of us were at our normal place of work, and it is likely to be many weeks, probably months, before we are back there. Videoconferencing is becoming second nature for us all.

AB - We are living in extraordinary times. COVID-19 is having a profound effect on every aspect of our lives. Most who read this will do so from their own homes. It will have been weeks since many of us were at our normal place of work, and it is likely to be many weeks, probably months, before we are back there. Videoconferencing is becoming second nature for us all.

KW - COVID-19

UR - http://www.scopus.com/inward/record.url?scp=85083410859&partnerID=8YFLogxK

U2 - 10.1186/s13063-020-04304-3

DO - 10.1186/s13063-020-04304-3

M3 - Editorial

C2 - 32293511

AN - SCOPUS:85083410859

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

M1 - 327

ER -

COVID-19 randomised trial protocols: Rapid publication without barriers

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this